Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF)
Hillary Bell is a highly experienced Senior Medical Science Liaison currently working at Medexus Pharmaceuticals since January 2025, following a similar role at Aurinia Pharmaceuticals Inc. from May 2023 to January 2025. Prior to these positions, Hillary served at AstraZeneca from December 2014 to January 2023, specializing in cardiometabolic disease within the Medical Affairs team. Additionally, Hillary has a solid foundation in patient care as a Physician Assistant, with roles at NYP, the Office of Dr. Jose Ortiz, Sherman Health Center, and the Office of Dr. Michael Strauss, culminating in comprehensive experience in oncology and internal medicine. Hillary is pursuing a Doctor of Medical Science degree in Organizational Leadership at A.T. Still University, building on a Master’s in Professional Studies from Mercy University and a Bachelor’s in Sports Medicine from SUNY New Paltz, along with certification in Health Coach Counseling from the Institute for Integrative Nutrition.
This person is not in any teams
This person is not in any offices
Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF)
Leading North American Specialty Pharmaceutical Company focused on hematology, rheumatology, auto-immune disease, specialty oncology and pediatrics.